Rezdiffra Tablet, Coated
Product Images NDC 82576-100
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Rezdiffra (NDC 82576-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Madrigal Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Description (Rezdiffra Bottle Label 100mg 30ct)
Image Description (Rezdiffra Bottle Label 100mg 90ct)
Image Description (Rezdiffra Bottle Label 60mg 30ct)
Image Description (Rezdiffra Bottle Label 80mg 30ct)
Image Description (Rezdiffra Bottle Label 80mg 90ct)
Image Description (Rezdiffra Carton Label 100mg 30ct)
Image Description (Rezdiffra Carton Label 100mg 90ct)
Image Description (Rezdiffra Carton Label 60mg 30ct)
Image Description (Rezdiffra Carton Label 80mg 30ct)
Image Description (Rezdiffra Carton Label 80mg 90ct)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.